Showing results (81-90 of 538) with videos related to
Sort By:
Pageof 54
Lung Cancer (Amsterdam, Netherlands)|January 24, 2012
Maintenance treatment of advanced non-small-cell lung cancer: results of an international expert panel meeting of the Italian association of thoracic oncologyCesare Gridelli, Filippo de Marinis, Massimo Di Maio, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
Second-line treatment of advanced non-small cell lung cancerCesare Gridelli, Andrea Ardizzoni, Fortunato Ciardiello, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panelCesare Gridelli, Matti Aapro, Andrea Ardizzoni, et al.Lung Cancer (Amsterdam, Netherlands)|February 25, 2012
Prognostic score for second-line chemotherapy of advanced non-small-cell lung cancer: external validation in a phase III trial comparing vinflunine with docetaxelMassimo Di Maio, Maciej Krzakowski, Ronan Fougeray, et al.Radiology and Oncology|September 30, 2017
Selection of Non-small Cell Lung Cancer Patients for Intercalated Chemotherapy and Tyrosine Kinase InhibitorsMatjaz Zwitter, Antonio Rossi, Massimo Di Maio, et al.Expert Review of Anticancer Therapy|October 14, 2020
Luteinized thecoma (thecomatosis) with sclerosing peritonitis: a systematic review of the literature of the last 25 yearsLeonardo Muratori, Elena Trevisi, Marco Donatello Delcuratolo, et al.Lung Cancer (Amsterdam, Netherlands)|March 29, 2011
Treatment of advanced non-small-cell lung cancer: Italian Association of Thoracic Oncology (AIOT) clinical practice guidelinesFilippo de Marinis, Antonio Rossi, Massimo Di Maio, et al.Cancer Treatment Reviews|January 31, 2017
Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancerConsuelo Buttigliero, Marcello Tucci, Francesca Vignani, et al.Lung Cancer (Amsterdam, Netherlands)|May 16, 2002
Carboplatin plus vinorelbine plus G-CSF in elderly patients with extensive-stage small-cell lung cancer: a poorly tolerated regimen. Results of a multicentre phase II studyCesare Gridelli, Antonio Rossi, Emiddio Barletta, et al.The Lancet. Oncology|September 19, 2014
Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient dataAntonio Rossi, Paolo Chiodini, Jong-Mu Sun, et al.Pageof 54